Skip to main content

Table 3 Cost components of selected studies

From: Cost of illness of breast cancer in low- and middle-income countries: a systematic review

Author

Total cost*

Direct cost

Inpatient

Follow-up visits

Surgery

Radiation

Labs

Medica-

tions

Direct non-medical cost

Home-help

Childcare

Transpor-tation

Accommodation

Indirect cost

Pakseresht et al. [21]

1146

(0–6186)

515

(0–3436)

NR

NR

NR

NR

29

(0–745)

229

(0–3436)

619

(0–3093)

NR

NR

344

(0–2749)

115

(0–1947)

NA

Lan et al. [27]

809

(SD 605)

809

(SD 605)

34

(SD 16)

471

(SD 344)

108

(SD 42)

30

(SD 50)

NR

630

(SD 996)

NA

NA

NA

NA

NA

NA

O’Neill et al. [20]

880

(298–8865)

195

(171–297)

NR

NR

NR

NR

NR

NR

676

(502–974)

NR

NR

NR

NR

NA

Shankar et al. [22]

825

(172–858)

825

(172–858)

NR

NR

NR

NR

NR

NR

NA

NA

NA

NA

NA

NA

Mahmood et al. [26]

2243

(SD 2106)

1534

(SD 1936)

NR

NR

281

(SD 413)

17

(SD 502)

299

(SD 196)

450

(SD 662)

378

(SD 365)

24

(SD 98)

2.86

(SD 31)

361

(SD 356)

16

(SD 67)

332

(SD 631)

Afkar et al. [24]

4808**

4808**

2081

553

749

NIL

403

1022

NA

NA

NA

NA

NA

NA

Afkar et al. [23]

private hospital

14,122

(SD 24,241)

11,866

(SD 23,000)

2161

(SD 1110)

673

(SD 1322)

1157

(SD 720)

649

(SD 1582)

2869

(SD 8785)

897

(SD 1417)

201

(SD 827)

NR

NR

177

(SD 815)

12

(SD 148)

2208

(SD 5821)

public hospital

27,122

(SD 14,948)

4676

(SD 8005)

1476

(SD 1830)

118

(SD 378)

230

(SD 396)

105

(SD 160)

502

(SD 1110)

313

(SD 626)

401

(SD 1063)

NR

NR

295

(SD 827)

1086

(SD 673)

26,390

(SD 21,997)

Rezende et al. [17]

377 million

(national prevalence)

377 million

69 million

NR

NR

53 million

NR

256 million

NA

NA

NA

NA

NA

NA

Zheng et al. [18]

78 million (Dalian city)

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Zhao et al. [19]

952

(708–1303)

952

(708–1303)

NR

NR

NR

NR

NR

NR

NA

NA

NA

NA

NA

NA

Jalali et al. [25]

12,818

(SD 8323)

9060

(SD 6761)

2264

(SD 1079)

243

(SD 5495)

NR

3594

(SD 3846)

598

(SD 320)

859

(SD 917)

2233

(SD 2108)

125

(SD 461)

873

(SD 694)

1525

(SD 3152)

1525

(SD 3152)

Umo et al. [28]

7248**

7248**

NR

NR

NR

NR

NR

NR

NA

NA

NA

NA

NA

NA

  1. *Total cost was reported as mean with ranges or mean with standard deviation (SD) per patient unless specified
  2. Costs were stated in USD for 2022 based on CCEMG – EPPI-Centre Cost Converter; Costs rounded to the nearest whole numbers
  3. NA, not applicable; NR, not recorded; SD, standard deviation
  4. ** Cost range or SD was not reported in original study